Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 506943 | NSE Symbol : JBCHEPHARM | ISIN : INE572A01036 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
21-Jul-2025	30-Jul-2025	Quarterly Results	JB Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2025 inter alia to consider and approve the unaudited financial results for the quarter ended on June 30 2025. Unaudited standalone and consolidated financial results for the quarter ended on June 30, 2025 accompanied by limited review report. (As Per BSE Announcement Dated on: 30/07/2025)
10-Jul-2025	10-Jul-2025	Change in Directors	Change in Director - Appointment of Non-Executive Independent Director
29-Jun-2025	29-Jun-2025	Change in Registered Address	Change in registered office of the Company Disclosure under Regulation 30 - Outcome of the Board meeting
28-Jun-2025	28-Jun-2025	Change in Directors	Re-appointment of Mr. Nikhil Chopra, Chief Executive Officer- Whole time- Director
22-Apr-2025	14-May-2025	Accounts	JB Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2025 inter alia to consider and approve (i) the audited financial results for the quarter and year ended on March 31 2025; and (ii) to consider and recommend dividend on equity shares of the Company if any subject to approval of shareholders. Recommendation of Final Dividend of Rs. 7 (700%) per equity share of FV of Re. 1 each for FY 2024-25 (As Per BSE Announcement dated on 14.05.2025)
24-Jan-2025	04-Feb-2025	Quarterly Results	J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2025 inter alia to consider and approve (i) unaudited financial results for the quarter and nine months ended on December 31 2024; and (ii) to consider declaration of Interim dividend if any for the financial year 2024-25. Declaration of interim dividend of Rs. 8.5 per equity share of Fv Re. 1 each for the FY 2024-25 Unaudited Financial Results for the quarter ended on December 31, 2024 (As per BSE Announcement Dated on 04/02/2025)
25-Oct-2024	06-Nov-2024	Quarterly Results	Quarterly Results Unaudited standalone and consolidated financial results for the quarter and half year ended on September 30, 2024 accompanied by limited review report (As Per BSE Announcement Dated on: 06/11/2024)
26-Jul-2024	08-Aug-2024	Quarterly Results	J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2024 inter alia to consider and approve unaudited financial results for the quarter ended on June 30 2024. Unaudited Financial Results for the quarter ended on June 30, 2024 (As Per BSE Announcement dated on 08.08.2024)
10-May-2024	17-May-2024	Final Dividend	J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2024 inter alia to consider and approve (i) the audited financial results for the year and quarter ended on March 31 2024; (ii) Consider and recommend Dividend on equity shares of the Company if any subject to approval of shareholders Recommendation of Final dividend of Rs. 6.75 per share of FV Re. 1(675%) for the FY 2023-24 (As Per BSE Announcement Dated on 15.05.2024)
30-Jan-2024	06-Feb-2024	Quarterly Results	J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2024 inter alia to consider and approve (1) Unaudited Financial Results for the quarter and nine months ended on December 31 2023; and (2) Declaration of Interim Dividend if any for the financial year 2023-24 Declaration of interim dividend of Rs. 5.50 per share(550%) for Fy 2023-24 Appointment of Chief Financial Officer (As Per BSE Announcement Dated on 06.02.2024)
30-Oct-2023	07-Nov-2023	Quarterly Results	J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 inter alia to consider and approve unaudited financial results for the quarter and half year ended on September 30 2023 Unaudited financial results for the quarter and half year ended on September 30, 2023 accompanied by limited review report Appointment of Non-Executive Director Amendment to the Employee Stock Option Scheme Grant of Options under Employee Stock Option Scheme Allotment of Equity shares on exercise of Stock options pursuant to the Employee Stock Scheme (As Per BSE Announcement Dated on 07/11/2023) Newspaper cutting of extract of consolidated financial results for the quarter and half year ended on September 30, 2023 (As Per BSE Announcement Dated on 08/11/2023)
01-Aug-2023	09-Aug-2023	Quarterly Results	J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2023 inter alia to consider and approve unaudited financial results for the quarter ended on June 30 2023. Unaudited Financial Results for the quarter ended on June 30, 2023 Setting-up of proposed step-down subsidiary Grant of options under Employee stock option scheme (As Per BSE Announcement Dated on 09.08.2023)
08-May-2023	24-May-2023	Final Dividend	J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2023 inter alia to consider and approve audited financial results for the year and quarter ended on March 31 2023 recommend final Dividend on equity shares of the Company if any and consider and approve the proposal to sub-divide/split the equity shares Outcome of the Board meeting- Audited standalone and consolidate financial results for the year ended on March 31, 2023 (I) The Board considered and approved sub-division/split of existing equity shares (ii) Recommended a final dividend of Rs. 9.25 (462.50 %) per equity share (As Per BSE Announcement dated on 24.05.2023)
01-Feb-2023	08-Feb-2023	Quarterly Results	Interim Dividend & Quarterly Results Declaration of interim dividend of Rs. 8.50 per share of FV Rs. 2 (425%) for FY 2022-2023 (As Per BSE Announcement Dated on 08.02.2023)
14-Dec-2022	13-Dec-2022	Acquisitions	Disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

1 2

LOGIN HERE

J B Chemicals & Pharmaceuticals Ltd

Board Meeting